-
1
-
-
84930709415
-
US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines
-
Saraiya M, Unger ER, Thompson TD, et al.; HPV Typing of Cancers Workgroup. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 2015;107:djv086. https://doi.org/10.1093/jnci/djv086
-
(2015)
J Natl Cancer Inst
, vol.107
-
-
Saraiya, M.1
Unger, E.R.2
Thompson, T.D.3
-
2
-
-
64849105830
-
A review of human carcinogens. Part b: Biological agents
-
Bouvard V, Baan R, Straif K, et al.; World Health Organization International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens. part b: biological agents. Lancet 2009;10:321–2. https://doi.org/10.1016/S1470-2045(09)70096-8
-
(2009)
Lancet
, vol.10
, pp. 321-322
-
-
Bouvard, V.1
Baan, R.2
Straif, K.3
-
3
-
-
84874043582
-
Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008
-
Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013;40:187–93. https://doi.org/10.1097/OLQ.0b013e318286bb53
-
(2013)
Sex Transm Dis
, vol.40
, pp. 187-193
-
-
Satterwhite, C.L.1
Torrone, E.2
Meites, E.3
-
4
-
-
84910056114
-
Vital signs: Cervical cancer incidence, mortality, and screening—United States, 2007–2012
-
Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M. Vital signs: cervical cancer incidence, mortality, and screening—United States, 2007–2012. MMWR Morb Mortal Wkly Rep 2014;63:1004–9.
-
(2014)
MMWR Morb Mortal Wkly Rep
, vol.63
, pp. 1004-1009
-
-
Benard, V.B.1
Thomas, C.C.2
King, J.3
Massetti, G.M.4
Doria-Rose, V.P.5
Saraiya, M.6
-
5
-
-
84944238751
-
Epidemiology of human papillomavirus–positive head and neck squamous cell carcinoma
-
Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus–positive head and neck squamous cell carcinoma. J Clin Oncol 2015;33:3235–42. https://doi.org/10.1200/JCO.2015.61.6995
-
(2015)
J Clin Oncol
, vol.33
, pp. 3235-3242
-
-
Gillison, M.L.1
Chaturvedi, A.K.2
Erson, W.F.3
Fakhry, C.4
-
6
-
-
85038855071
-
Understanding personal risk of oropharyngeal cancer: Risk-groups for oncogenic oral HPV infection and oropharyngeal cancer
-
D’Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol 2017;28:3065–9. https://doi.org/10.1093/annonc/mdx535
-
(2017)
Ann Oncol
, vol.28
, pp. 3065-3069
-
-
D’Souza, G.1
McNeel, T.S.2
Fakhry, C.3
-
7
-
-
85049857069
-
-
Rockville, MD: Guide to Community Preventive Service
-
United States Preventive Services Task Force. Published recommendations. Rockville, MD: Guide to Community Preventive Service; 2018. https://www.uspreventiveservicestaskforce.org/BrowseRec/Index/browse-recommendations.
-
(2018)
Published Recommendations
-
-
-
8
-
-
85042786974
-
Ten years of human papillomavirus vaccination in the United States
-
Markowitz LE, Gee J, Chesson H, Stokley S. Ten years of human papillomavirus vaccination in the United States. Acad Pediatr 2018;18(2S):S3–10. https://doi.org/10.1016/j.acap.2017.09.014
-
(2018)
Acad Pediatr
, vol.18
, Issue.2S
, pp. S3-S10
-
-
Markowitz, L.E.1
Gee, J.2
Chesson, H.3
Stokley, S.4
-
9
-
-
84929509772
-
Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices
-
Petrosky E, Bocchini JA Jr, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2015;64:300–4.
-
(2015)
MMWR Morb Mortal Wkly Rep
, vol.64
, pp. 300-304
-
-
Petrosky, E.1
Bocchini, J.A.2
Hariri, S.3
|